ArticleCost effectiveness and resource allocation : C/E2023

Methodology and results of cost-effectiveness of LDL-C lowering with evolocumab in patients with acute myocardial infarction in China.

Yuansheng Wan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.